Venetoclax in combination with low-dose cytarabine – a promising regimen for the treatment of AML
FCR or FR – which regimen is better for treating CLL?
The latest data in diffuse large B-cell lymphoma from ICML 2017
Advances in low grade lymphoma over the past 40 years
How the management of CLL is evolving